Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market
Holding VRAX?
Track your performance easily

Virax Biolabs Group Ltd. Class A (VRAX) Cash flow

33 Followers

Virax Biolabs Group Ltd. Class A Cash Flow

VRAX's free cash flow for Q was $―. For the fiscal year, VRAX's free cash flow was decreased by $-3.89M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
-$ -4.33M$ -618.40K$ -590.19K$ -744.61K
Investing Cash Flow
-$ -178.40K---
Financing Cash Flow
-$ 13.80M$ 619.61K$ 585.20K$ 704.64K
Cash Flow From Discontinued Operation
-----
Other Cash Adjustment Inside Changein Cash
-----
End Cash Position
-$ 9.32M$ 18.84K$ 17.62K$ 22.61K
Income Tax Paid Supplemental Data
---$ 0.00$ 0.00
Interest Paid Supplemental Data
---$ 0.00$ 0.00
Issuance Of Capital Stock
-$ 13.65M$ 519.61K--
Issuance Of Debt
---$ 0.00-
Repayment Of Debt
-----
Free Cash Flow
-$ -4.50M$ -618.40K$ -590.19K$ -744.61K
Domestic Sales
-----
Foreign Sales
-----
Currency in USD

Virax Biolabs Group Ltd. Class A Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis